{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T16:35:39Z","timestamp":1791218139356,"version":"4.1.0"},"reference-count":24,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,1,30]]},"DOI":"10.1097\/qad.0b013e328011efac","type":"journal-article","created":{"date-parts":[[2007,1,24]],"date-time":"2007-01-24T04:03:11Z","timestamp":1169611391000},"page":"335-341","source":"Crossref","is-referenced-by-count":250,"title":["Tuberculosis-associated immune reconstitution disease: incidence, risk factors and impact in an antiretroviral treatment service in South Africa"],"prefix":"10.1097","volume":"21","author":[{"given":"Stephen D","family":"Lawn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Landon","family":"Myer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda-Gail","family":"Bekker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin","family":"Wood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-7-20210130","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1001\/archinte.163.9.1009","article-title":"The growing burden of tuberculosis: global trends and interactions with the HIV epidemic","volume":"163","author":"Corbett","year":"2003","journal-title":"Arch Intern Med"},{"key":"R2-7-20210130","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1086\/501018","article-title":"Impact of HIV infection on the epidemiology of tuberculosis in a peri-urban community in South Africa: the need for age-specific interventions","volume":"42","author":"Lawn","year":"2006","journal-title":"Clin Infect Dis"},{"key":"R3-7-20210130","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1097\/01.aids.0000238406.93249.cd","article-title":"Burden of tuberculosis in an antiretroviral treatment programme in sub-Saharan Africa: impact on treatment outcomes and implications for tuberculosis control","volume":"20","author":"Lawn","year":"2006","journal-title":"AIDS"},{"key":"R5-7-20210130","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1097\/00002030-200201040-00010","article-title":"Treatment of tuberculosis in HIV-infected persons in the era of highly active antiretroviral therapy","volume":"16","author":"Dean","year":"2002","journal-title":"AIDS"},{"key":"R6-7-20210130","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1146\/annurev.med.55.091902.103753","article-title":"Clinical management of tuberculosis in the context of HIV infection","volume":"55","author":"de Jong","year":"2004","journal-title":"Annu Rev Med"},{"key":"R7-7-20210130","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1056\/NEJM199902043400507","article-title":"Tuberculosis in patients with human immunodeficiency virus infection","volume":"340","author":"Havlir","year":"1999","journal-title":"N Engl J Med"},{"key":"R8-7-20210130","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1164\/ajrccm.164.1.2101133","article-title":"Treatment of HIV-related tuberculosis in the era of effective antiretroviral therapy","volume":"164","author":"Burman","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"key":"R9-7-20210130","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1086\/425742","article-title":"Determinants of immune reconstitution inflammatory syndrome in HIV type 1-infected patients with tuberculosis after initiation of antiretroviral therapy","volume":"39","author":"Breton","year":"2004","journal-title":"Clin Infect Dis"},{"key":"R10-7-20210130","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S1473-3099(05)70140-7","article-title":"Immune reconstitution disease associated with mycobacterial infections in HIV-infected individuals receiving antiretrovirals","volume":"5","author":"Lawn","year":"2005","journal-title":"Lancet Infect Dis"},{"key":"R11-7-20210130","first-page":"315","article-title":"Rapid scale-up of a community-based HIV treatment service: programme performance over 3 consecutive years in Guguletu, South Africa","volume":"96","author":"Bekker","year":"2006","journal-title":"S Afr Med J"},{"key":"R12-7-20210130","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1097\/01.aids.0000194802.89540.e1","article-title":"Early mortality among adults accessing a community-based antiretroviral service in South Africa: implications for programme design","volume":"19","author":"Lawn","year":"2005","journal-title":"AIDS"},{"key":"R13-7-20210130","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1086\/507095","article-title":"Determinants of mortality and nondeath losses from an antiretroviral treatment service in South Africa: implications for program evaluation","volume":"43","author":"Lawn","year":"2006","journal-title":"Clin Infect Dis"},{"key":"R14-7-20210130","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/1471-2334-6-59","article-title":"CD4 cell count recovery among HIV-infected patients with very advanced immunodeficiency commencing antiretroviral treatment in sub-Saharan Africa","volume":"6","author":"Lawn","year":"2006","journal-title":"BMC Infect Dis"},{"key":"R15-7-20210130","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1097\/01.aids.0000191232.16111.f9","article-title":"Cryptococcocal immune reconstitution disease: a major cause of early mortality in a South African antiretroviral programme","volume":"19","author":"Lawn","year":"2005","journal-title":"AIDS"},{"key":"R18-7-20210130","article-title":"Applied Logistic Regression","author":"Hosmer","year":"2004"},{"key":"R19-7-20210130","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1378\/chest.120.1.193","article-title":"Paradoxical worsening of tuberculosis in HIV-infected persons","volume":"120","author":"Wendel","year":"2001","journal-title":"Chest"},{"key":"R20-7-20210130","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1136\/thx.2003.019224","article-title":"Paradoxical reactions during tuberculosis treatment in patients with and without HIV co-infection","volume":"59","author":"Breen","year":"2004","journal-title":"Thorax"},{"key":"R21-7-20210130","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1164\/ajrccm.158.1.9712001","article-title":"Paradoxical worsening of tuberculosis following antiretroviral therapy in patients with AIDS","volume":"158","author":"Narita","year":"1998","journal-title":"Am J Respir Crit Care Med"},{"key":"R22-7-20210130","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1097\/01.aids.0000161769.06158.8a","article-title":"Incidence and risk factors for immune reconstitution inflammatory syndrome during highly active antiretroviral therapy","volume":"19","author":"Shelburne","year":"2005","journal-title":"AIDS"},{"key":"R23-7-20210130","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1097\/00126334-200412150-00007","article-title":"Incidence of immune reconstitution syndrome in HIV\/tuberculosis-coinfected patients after initiation of generic antiretroviral therapy in India","volume":"37","author":"Kumarasamy","year":"2004","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R25-7-20210130","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1097\/01.aids.0000176211.08581.5a","article-title":"How effectively does HAART restore immune responses to Mycobacterium tuberculosis? Implications for tuberculosis control","volume":"19","author":"Lawn","year":"2005","journal-title":"AIDS"},{"key":"R26-7-20210130","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1086\/503437","article-title":"Virological response to highly active antiretroviral therapy is unaffected by antituberculosis therapy","volume":"193","author":"Breen","year":"2006","journal-title":"J Infect Dis"},{"key":"R27-7-20210130","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1097\/01.aids.0000196181.18916.9b","article-title":"Efavirenz 600 mg\/day versus efavirenz 800 mg\/day in HIV-infected patients with tuberculosis receiving rifampicin: 48 weeks results","volume":"20","author":"Manosuthi","year":"2006","journal-title":"AIDS"},{"key":"R28-7-20210130","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1086\/508549","article-title":"Impact of antituberculosis treatment on virological response to highly active antiretroviral therapy: implications for resource-limited settings","volume":"194","author":"Lawn","year":"2006","journal-title":"J Infect Dis"}],"container-title":["AIDS"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/QAD.0b013e328011efac","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T16:23:12Z","timestamp":1786033392000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00002030-200701300-00007"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,1,30]]},"references-count":24,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2007]]}},"URL":"https:\/\/doi.org\/10.1097\/qad.0b013e328011efac","relation":{},"ISSN":["0269-9370"],"issn-type":[{"value":"0269-9370","type":"print"}],"subject":[],"published":{"date-parts":[[2007,1,30]]}}}